Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Male Reproductive SystemDRG 715-other-male-reproductive-system-o-r-procedures-for-malignancy-with-cc-mcc
    Ask Trek AI about this page

    Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC: Inpatient Reimbursement Overview

    DRG 715 encompasses other operative procedures on the male reproductive system for malignancy with Complication or Comorbidity or Major Complication or Comorbidity, defining the clinical scope for inpatient grouping. It matters for inpatient reimbursement because the Complication or Comorbidity or Major Complication or Comorbidity status raises the payment weight and affects Medicare inpatient claims processing.

    Customize your policy alerts

    Sign up for drg 715 policy alerts

    Get alerted when payer policies referencing 715 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 715 Overview

    DRG 715 covers other operative procedures on the male reproductive system performed for malignancy when a Complication or Comorbidity or a Major Complication or Comorbidity is present. Typical cases include non-prostate malignancy procedures such as orchiectomy, surgical excision, or reconstructive operations coded as malignant diagnoses with associated complications. This Diagnosis-Related Group matters for Medicare payment because the presence of Complication or Comorbidity or Major Complication or Comorbidity elevates the relative weight and influences inpatient reimbursement under Centers for Medicare & Medicaid Services payment policies. Facilities and coders must accurately capture operative and secondary diagnosis codes to ensure appropriate grouping and payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative outcomes and complication-reduction trials: studies that evaluate interventions to reduce intraoperative and immediate postoperative complications in patients undergoing open or minimally invasive male reproductive system surgeries for malignancy (such as radical orchiectomy with complex reconstruction or retroperitoneal lymph node dissection). These trials typically enroll adult men with primary or recurrent genitourinary malignancies requiring operative management and compare perioperative protocols (enhanced recovery pathways, anesthesia strategies, antibiotic prophylaxis timing, or blood-conservation techniques). Results inform surgeons and hospital administrators about approaches that reduce length of stay, readmissions, and resource use, which directly affect inpatient reimbursement and DRG-based cost management.
    • Comparative effectiveness studies of surgical approaches and extent of resection: randomized or pragmatic registry-based studies comparing different operative strategies (for example, organ-sparing procedures versus more extensive resection, or open versus laparoscopic/robotic approaches) in patients with localized or regionally advanced male reproductive malignancies. These studies focus on functional outcomes, oncologic control, perioperative morbidity, and need for subsequent inpatient care, enrolling patients stratified by tumor stage, prior treatments, and comorbidity burden. Findings help clinicians choose procedures that balance cancer control with complication risk and inform payers and hospitals about likely downstream utilization and DRG assignment variability tied to complications or CC/MCC status.
    • Post-discharge and survivorship outcomes research including readmission and long-term functional recovery: observational cohort studies and prospective registries that follow patients after discharge from index surgical admission to measure readmission drivers, late complications (lymphedema, sexual dysfunction, urinary issues), need for rehabilitation or additional inpatient stays, and quality-of-life trajectories. These studies enroll the heterogeneous population captured under DRG 715 — often older men with comorbidities and cancer-related complications — to quantify predictors of costly readmissions and prolonged care needs. Such evidence is essential for care pathways, case management, and payer planning to reduce avoidable inpatient utilization and to refine risk-adjusted reimbursement models tied to CC/MCC prevalence.

    Related Codes

    707-MAJOR-MALE-PELVIC-PROCEDURES-WITH-CC-MCC

    Major Male Pelvic Procedures with CC/MCC: Inpatient Reimbursement Overview

    708-MAJOR-MALE-PELVIC-PROCEDURES-WITHOUT-CC-MCC

    Major Male Pelvic Procedures without CC/MCC: Inpatient Reimbursement Overview

    709-PENIS-PROCEDURES-WITH-CC-MCC

    Penis Procedures with CC/MCC: Inpatient Reimbursement Overview

    710-PENIS-PROCEDURES-WITHOUT-CC-MCC

    Penis Procedures without CC/MCC: Inpatient Reimbursement Overview

    711-TESTES-PROCEDURES-WITH-CC-MCC

    Testes Procedures with CC/MCC: Inpatient Reimbursement Overview

    712-TESTES-PROCEDURES-WITHOUT-CC-MCC

    Testes Procedures without CC/MCC: Inpatient Reimbursement Overview

    713-TRANSURETHRAL-PROSTATECTOMY-WITH-CC-MCC

    Transurethral Prostatectomy with CC/MCC: Inpatient Reimbursement Overview

    714-TRANSURETHRAL-PROSTATECTOMY-WITHOUT-CC-MCC

    Transurethral Prostatectomy without CC/MCC: Inpatient Reimbursement Overview

    716-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITHOUT-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC: Inpatient Reimbursement Overview

    717-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-EXCEPT-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures Except Malignancy with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 20

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.